Public policies are critical to the ability of children’s
hospitals to care for all children, through clinical care, training,
research and public health advocacy. As health care policies are debated
at the state and federal levels, The Children's Hospital Association and
its member hospitals work with policymakers to ensure children’s
unique health care needs are not overlooked and that every child has
access to high quality, cost effective primary, preventive and specialty
care services tailored to meet their needs. Find
out more about the Children's Hospital Association.
|Association Public Policy Update Conference Calls- July 28, 2014|
The Children's Hospital Association invites government relations and other member hospital professionals to participate in weekly, half-hour conference calls on the latest news from Washington.
|Washington Update- July 25, 2014|
The Association urges member hospitals to reach out to their congressional delegations to cosponsor the ACE Kids Act of 2014, H.R. 4930. On the regulatory front, the Association submits comments to CMS on the electronic health record proposed rule.
|Chart of Administrative Actions- July 23, 2014|
Pending regulations and other guidance shown on this chart allows children’s hospitals to track administrative actions throughout the regulatory process.
|Modifications to the Medicare and Medicaid Electronic Health Record Incentive Programs for 2014 (Association Comment Letter)- July 18, 2014|
In May the Centers for the Medicare and Medicaid Services issued a proposed rule that would change the meaningful use stage timeline and definition of certified electronic health record technology for 2014. The Children’s Hospital Association submitted a comment letter expressing appreciation for the additional flexibility and outlining a few outstanding questions.
|Washington Update- July 18, 2014|
The Association continues to ask member hospitals to reach out to their congressional delegations and urge cosponsorship of H.R. 4930, the ACE Kids Act of 2014. On the regulatory front, the timing of the 340B drug pricing “mega reg” remains unclear, and HRSA’s CHGME funding opportunity deadline is delayed.